Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.

A new Cedars Sinai Physician Associated Study used the processes and care of Daybreak to evaluate a dentist-led, ...

When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3% ...

Marius Pharmaceuticals, Inc. today announced the company will initiate a new post-marketing clinical study for potential label expansion evaluating KYZATREX® (testosterone undecanoate) CIII capsules ...

PLYMOUTH MEETING, Pa.-- (BUSINESS WIRE)--January 12, 2026-- ...

Professor Johan Verbraecken, shares insights on a recent ERS consensus statement on advanced telemedicine in obstructive ...

INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single ...

Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been enrolled in its new Phase 2b clinical trial ( CAPTAIN-T2D, NCT07296484) ...

Setting an alarm to go off an hour before your bedtime every night can remind you that it’s time to start getting ready for ...

Sleep training debates polarize parents into opposing camps, but neither side is entirely right. We need a more nuanced, inclusive approach that offers parents options.

University of Texas at Dallas researchers, in partnership with Texas-based biotech company EnLiSense, have demonstrated a ...